VAERS COVID Vaccine
Adverse Event Reports
1,424,789 Reports Through September 23, 2022
- 31,214 DEATHS
- 178,971 HOSPITALIZATIONS
- 136,146 URGENT CARE
- 206,875 DOCTOR OFFICE VISITS
- 10,042 ANAPHYLAXIS
- 16,071 BELL’S PALSY
- 5,055 Miscarriages
- 16,737 Heart Attacks
- 52,713 Myocarditis/Pericarditis
- 58,403 Permanently Disabled
- 9,081 Thrombocytopenia/Low Platelet
- 34,216 Life Threatening
- 44,859 Severe Allergic Reaction
- 14,755 Shingles
COVID Vaccine Reports in Children
(Ages 6 mos.-17 years)
Through September 23, 2022
- 56,110 Total Reports
- 153 Deaths
- 523 Permanently Disabled
- 1,949 Myocarditis
- 670 Life Threatening
- 4,415 Hospitalized
- 5,220 ER Visit
- 9,969 Not Recovered
86% of kids under 17 have antibodies
From an ABC news report dated October 6, 2022
More than eight in 10 kids under the age of 17 have antibodies from a past COVID-19 infection, according to new data from the Centers for Disease Control and Prevention.
The analysis shows that as of August, 86% of children between 6 months and 17 years old have had at least one COVID infection since the pandemic began.
That number is an increase from data in April when the public health agency found that 75% of people under the age of 17 had been infected with the virus.
The CDC of source put a caveat on the findings stating that it doesn’t mean they won’t be reinfected. They urge parents to make sure they get the death jab so they won’t be infected. But I thought they said that the shot won’t guarantee they won’t get sick, so … what’s the difference?
Is the U.S. Blood Supply Tainted?
Report from Children's Health Defense Team - October 6, 2022
Despite reports that COVID-19 vaccines cause blood abnormalities, the American Red Cross and the U.S. Food and Drug Administration continue to brush off concerns that the massive vaccine campaign may have contaminated the country’s blood supply.
After the U.S. Food and Drug Administration’s (FDA’s) Emergency Use Authorization (EUA) of COVID-19 vaccines, blood clots were some of the earliest adverse events observed, and abnormal coagulation continues to be one of the most frequent and serious problems reported.
As of mid-September, the Vaccine Adverse Event Reporting System (VAERS) — notorious for capturing only a minuscule proportion of adverse events — had received notification of more than 43,000 blood clotting disorders, including acute-onset problems in young children.
Clotting disorders make the blood clot “too easily,” generating clots that can travel through the bloodstream and increase the risk of heart attacks and strokes, among other potential complications.
No ‘safety risks?’
Depending on their blood type, individuals who give blood can choose to donate whole blood, plasma or platelets, or they can make a “Power Red” donation (a “concentrated dose” of red blood cells).
The American Red Cross says it will not accept blood from someone whose blood “does not clot normally,” but — following guidance from the same branch of the FDA that oversees vaccines — welcomes immediate donations from anyone who received one of the mRNA or other COVID-19 vaccines available in the U.S., as long as the person says he is “symptom-free and feeling well.”
In a recent tweet directed at potential blood transfusion recipients, the Red Cross clarified:
The tweet generated numerous responses from the public accusing the Red Cross of disseminating “misinformation” and directing the organization’s attention to peer-reviewed publications contradicting its languid attitude.
Anyone who has taken high school biology knows that antibodies are created in the blood. How do they expect ANY vaccine to ‘assist’ in creating new antibodies if it doesn’t enter the bloodstream? These elite POS’s think we are all idiots!
The Monkeypox Virus Is Mutating. Are Scientists Worried?
Report from Nature news dated October 5, 2022
As researchers at the Minnesota Department of Health in St. Paul were sequencing samples of the monkeypox virus a few months ago, they made a surprising discovery. In one sample collected from an infected person, a large chunk of the virus’s genome was missing, and another chunk had moved to an entirely different spot in the sequence.
Although scientists aren’t alarmed, they are monitoring the situation carefully to understand why the alterations have appeared, and what they might mean for the global monkeypox outbreak. These mutations are a stark reminder that even poxviruses — which are DNA viruses that tend to evolve more slowly than RNA viruses, such as the SARS-CoV-2 coronavirus — will change over time, says Elliot Lefkowitz, a computational virologist at the University of Alabama at Birmingham. And the more the monkeypox virus is transmitted between humans, he adds, the more opportunities it will have to evolve.
COVID Vaccination Cause of Acquired Hemophilia A
From a report by Hemophilia News Today dated October 5, 2022
COVID-19 vaccines, because they work to stimulate the immune system, may be an emerging cause of autoimmune conditions like acquired hemophilia A, according to a case report. “This report aims to highlight the risk of … [acquired hemophilia A] following an immune stimulus, thus improving our knowledge regarding possible vaccination-related adverse events,” the researchers wrote.
Acquired hemophilia is a very rare condition caused by the development of self-reactive antibodies against certain coagulation factors — proteins needed for proper blood clotting. In the case of acquired hemophilia A, these antibodies target clotting factor VIII (FVIII).
For about half of these people, the cause of this immune overactivation is never established. For others, illnesses like cancer, infections, or vaccinations have been reported to spur disease onset.
71-year-old Italian had no history of bleeding disorders
Researchers reported a case of acquired hemophilia A following COVID-19 vaccination in a 71-year-old-man admitted to their hospital in Italy. The man had previously been admitted to another emergency center with symptoms of arm pain and swelling associated with limited movement and petechiae (tiny spots of bleeding under the skin). He sought help eight days after a second dose of the Pfizer-BioNTech COVID-19 vaccine.
The case, involving a man who developed the bleeding condition after receiving the vaccine and was initially treated improperly, also highlights the importance of educating physicians about this potential side effect. The case report, “Acquired hemophilia A following COVID-19 vaccination — The importance of prompt diagnosis: A case report,” was published in the journal Transfusion and Apheresis Science.